Women and men with coronary heart disease respond similarly to different aerobic exercise training modalities: a pooled analysis of prospective randomized trials.

adaptation à l’entraînement aerobic exercise training cardiopulmonary exercise test coronary heart disease différences liées au sexe entraînement à l’exercice aérobie maladie coronarienne pic de V̇O2 sex-differences training response épreuve d’effort cardiopulmonaire ̇VO2peak

Journal

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
ISSN: 1715-5320
Titre abrégé: Appl Physiol Nutr Metab
Pays: Canada
ID NLM: 101264333

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 24 10 2020
medline: 5 11 2021
entrez: 23 10 2020
Statut: ppublish

Résumé

We aimed to compare cardiopulmonary exercise test (CPET) parameters, cardiac adaptations, and proportion of responders after different aerobic training programs amongst women and men with coronary heart disease (CHD). Patients with CHD were evaluated with a CPET and echocardiography before and after 3 months of aerobic exercise training. Peak oxygen uptake exercise training response was assessed according to the median peak oxygen uptake change for post- versus pretraining in the whole cohort (stratification non/low responders (NLR) vs. high-responders) and normalized for lean body mass (LBM). Eighty-three CHD patients were included (19 women, 64 men; 27 patients with interval, 19 with continuous, and 37 with combination exercises). Peak oxygen uptake, peak workload normalized for LBM, pulmonary variables (i.e., ventilation and oxygen uptake efficiency slope), and O

Identifiants

pubmed: 33096006
doi: 10.1139/apnm-2020-0650
doi:

Banques de données

ClinicalTrials.gov
['NCT03414996', 'NCT02048696', 'NCT03443193']

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

417-425

Auteurs

Lukas-Daniel Trachsel (LD)

Cardiovascular Prevention and Rehabilitation (ÉPIC) Center, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1N6, Canada.
Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
University Clinic for Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, CH-3010 Switzerland.

Maxime Boidin (M)

Cardiovascular Prevention and Rehabilitation (ÉPIC) Center, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1N6, Canada.
Research Centre, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1C8, Canada.
School of Kinesiology and Exercise Science, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.

Christine Henri (C)

Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Research Centre, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1C8, Canada.

Annik Fortier (A)

Montreal Health Innovations Coordinating Center, Montreal Heart Institute, Montreal, QC H1T 1C8, Canada.

Julie Lalongé (J)

Cardiovascular Prevention and Rehabilitation (ÉPIC) Center, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1N6, Canada.
Research Centre, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1C8, Canada.

Martin Juneau (M)

Cardiovascular Prevention and Rehabilitation (ÉPIC) Center, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1N6, Canada.
Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Research Centre, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1C8, Canada.

Anil Nigam (A)

Cardiovascular Prevention and Rehabilitation (ÉPIC) Center, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1N6, Canada.
Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Research Centre, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1C8, Canada.

Mathieu Gayda (M)

Cardiovascular Prevention and Rehabilitation (ÉPIC) Center, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1N6, Canada.
Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Research Centre, Montreal Heart Institute, Université de Montréal, Montreal, QC H1T 1C8, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH